Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure
出版年份 2015 全文链接
标题
Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure
作者
关键词
Intensive Care Unit Patient, Caspofungin, Invasive Candidiasis, Micafungin, Population Pharmacokinetic Model
出版物
CLINICAL PHARMACOKINETICS
Volume 55, Issue 6, Pages 723-733
出版商
Springer Nature
发表日期
2015-12-11
DOI
10.1007/s40262-015-0347-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents
- (2014) Stijn I. Blot et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetics of caspofungin in ICU patients
- (2014) E. W. Muilwijk et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive Aspergillosis
- (2013) Gudrun Würthwein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Weight Drives Caspofungin Pharmacokinetic Variability in Overweight and Obese People: Fractal Power Signatures beyond Two-Thirds or Three-Fourths
- (2013) Ronald G. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Body Mass Index Is Associated With Hospital Mortality in Critically Ill Patients
- (2013) Peter Pickkers et al. CRITICAL CARE MEDICINE
- A Pharmacokinetic Standard for Babies and Adults
- (2013) Nick Holford et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
- (2012) D. R. Andes et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients
- (2011) Gudrun Würthwein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fractal Geometry and the Pharmacometrics of Micafungin in Overweight, Obese, and Extremely Obese People
- (2011) Ronald G. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
- (2011) O. A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
- (2011) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
- (2010) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Piraña and PCluster: A modeling environment and cluster infrastructure for NONMEM
- (2010) Ron J. Keizer et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Echinocandin pharmacodynamics: review and clinical implications
- (2010) M. W. Pound et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
- (2009) Robert F. Betts et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
- (2009) Brian J. Anderson et al. Drug Metabolism and Pharmacokinetics
- International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
- (2009) Jean-Louis Vincent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins andCandidaspp.
- (2009) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model
- (2008) D. R. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started